Using sophisticated research methods to study the way biology and behavior impact each other during GLP-1 therapy will help us to understand mechanisms that lead to the variable experiences people have on these medications with respect to weight, quality of life, substance use and others. The researchers hope the project will demonstrate the strength of collaboration across institutions and research settings, including two major research hubs within the Sanford Health System in Fargo and Sioux Falls, NDSU and the Center for Advancement in Pharmacy at NDSU
Medications like orforglipron (an oral, non-peptide GLP-1 agonist), survodutide (a dual glucagon/GLP-1 agonist), and CagriSema (combining cagrilintide with semaglutide) are advancing through clinical trials
Similarly, if food noise is accompanied by compensatory behaviours such as excessive exercise, purging, or severe restriction, this may suggest an eating disorder requiring specialist intervention
This 30-45 minute process involves microscopic laser beams that penetrate into the dermis, stimulating the formation of new, healthy tissue
Step 1: The Warm-up Begin with a warm-up dose of 0.25 mg once a week for the first four weeks
But insurance companies want to keep costs down themselves, so many won't cover them for weight loss, or require patients to jump through frustrating hoops to get approval for coverage
